Furthermore, we compared postmortem lung samples of COVID-19 patients (n = 6) with lung sections of other pneumonia patients (n = 3) or deceased due to other causes (n = 3) by immunohistochemical staining of P62 and LC3B (Supplementary Tables 5, 6). This evidence concerns the gene MAP1LC3B and susceptibility to pneumonia measurement.